Safety of potential breast milk exposure to IFN-{beta} or glatiramer acetate: One-year infant outcomes

Conclusion Potential breast milk exposure to IFN-β or GA did not increase the risk of common adverse infant outcomes in the first year of life. Taken together with the benefits of breastfeeding and low biological plausibility of risk, women with MS who wish to resume IFN-β or GA postpartum can be encouraged to breastfeed.

http://nn.neurology.org/cgi/content/short/7/4/e757?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - May 19, 2020 Category: Neurology Authors: Ciplea, A. I., Langer-Gould, A., Stahl, A., Thiel, S., Queisser-Wahrendorf, A., Gold, R., Hellwig, K. Tags: Multiple sclerosis, Cohort studies Article Source Type: research